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Background
Hereditary Breast and Ovarian Cancer (HBOC) syn-
drome due to mutations in BRCA1 and BRCA2 is asso-
ciated with an increase in risk for primarily breast
cancer and ovarian cancer. Lynch syndrome (LS), due to
mutations in MLH1, MSH2, MSH6, and PMS2 is typi-
cally associated with an increase in risk for chiefly color-
ectal cancer and endometrial cancer. Ovarian cancer risk
is also increased in LS, however less so than in HBOC.
Method
We describe a rare presentation of LS, diagnosed in a
patient who presented at the age of 41 with a suspected
primary ovarian cancer. Her family history was signifi-
cant for a sister with breast cancer at the age of 29
found to carry a BRCA1 variant of uncertain signifi-
cance; a mother who passed away from ovarian cancer;
and a father with prostate cancer, and a paternal family
history significant for breast cancer, pancreatic cancer,
and a possible ovarian cancer. No colorectal or endome-
trial carcinoma was reported in maternal or paternal
family history.
Result
Calculated BRCAPRO likelihood of a BRCA1/2 muta-
tion, with a primary ovarian carcinoma as the probands
diagnosis, was 90.2% [1]. Full clinical testing for muta-
tions in BRCA1 and BRCA2 was pursued and was nega-
tive for any deleterious mutations or variants of
uncertain significance in this patient.
Pathologic analysis of the patient’s resected ovarian
mass reported suspicion of GI or hepatobiliary origin
due to positive staining for CK7, CEA and CK20. Due
to the history of multiple ovarian tumors in the family;
the possibility of a primary GI tumor at a young age in
the probands; and the negative HBOC testing; LS
genetic testing was pursued and detected a deleterious
MSH2 mutation, IVS5+3A>T. Appropriate testing and
surveillance for Lynch Syndrome associated cancers for
the patient and at risk relatives can now be pursued.
Conclusion
This case emphasizes the importance of consideration of
Lynch syndrome as well as HBOC in all families present-
ing with multiple ovarian cancers and the crucial element
which pathology plays in accurate risk assessment.
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